Unidade Local De Saude Do Alto Minho E.P.E.

At Unidade Local De Saude Do Alto Minho E.P.E., research in rheumatology strongly focuses on autoimmune and inflammatory diseases, especially Sjögren’s Syndrome, giant cell arteritis, and rheumatoid arthritis. The studies are designed to better understand disease activity and to evaluate new treatments that may improve symptoms, control inflammation, and support long-term care.

• Sjögren’s Syndrome studies assessing symptom relief and effects on systemic disease activity
• Giant cell arteritis research aimed at improving sustained remission and treatment effectiveness
• Rheumatoid arthritis trials exploring new options to reduce disease burden

These trials reflect a broad effort to advance care for chronic immune-mediated conditions, with a focus on both patient-reported outcomes and clinical improvement.

The site also conducts clinical research in musculoskeletal diseases, with emphasis on psoriatic arthritis, juvenile psoriatic arthritis, and erosive/inflammatory osteoarthritis of the hands. The main purpose is to test new therapies and compare treatment approaches that may help reduce pain, stiffness, and joint inflammation.

• Psoriatic arthritis studies evaluating symptom control and treatment response
• Juvenile psoriatic arthritis research focused on treatment options for children and adolescents
• Hand osteoarthritis trials looking at pain reduction and functional improvement

This research supports better management of both adult and pediatric joint disease, while also examining longer-term safety and tolerability of emerging therapies.

Clinical trials at this hospital in Ponte De Lima include important work in skin and connective tissue diseases, particularly diffuse cutaneous systemic sclerosis and related complications such as interstitial lung disease secondary to systemic sclerosis. These studies aim to evaluate whether new treatments can improve organ involvement, breathing-related outcomes, and overall disease control.

• Diffuse cutaneous systemic sclerosis research focused on disease progression and treatment benefit
• Systemic sclerosis-associated interstitial lung disease studies examining lung function and clinical response
• Connective tissue disease trials assessing safety, tolerability, and symptom improvement

Overall, this area of research is centered on finding more effective ways to manage complex systemic conditions that affect the skin, lungs, and other organs.

Research in respiratory tract diseases is closely linked to systemic autoimmune conditions at the site, especially studies involving lung function in systemic sclerosis. The trials are intended to assess whether investigational therapies can slow respiratory decline and help preserve breathing capacity in affected patients.

• Interstitial lung disease linked to systemic sclerosis
• Forced vital capacity as a key measure of treatment impact
• Therapies being tested for their ability to support respiratory health

This work highlights the connection between rheumatic disease and lung involvement, with a strong focus on improving measurable respiratory outcomes.